Rituximab is more effective and better tolerated than fingolimod for patients with multiple sclerosis needing to switch from natalizumab due to JC-virus antibody positivity, research suggests. (Source: MedWire News)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Read full article on medworm.com

Powered by Preisvergleich